HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection.

AbstractOBJECTIVE:
To evaluate the effectiveness of more than 12 months of oral acyclovir therapy in reducing recurrences of ocular herpes simplex virus.
METHODS:
We retrospectively compared ocular herpes simplex virus recurrence in 2 groups of patients. In group 1, patients used oral acyclovir for at least 12 months and then discontinued the treatment. In group 2, patients received the treatment for at least 18 months. We compared recurrences when both groups were using acyclovir (period 1) and when only group 2 was receiving the drug (period 2). Statistical analysis was performed with the t test, chi2 test, and Kaplan-Meier method.
RESULTS:
Group 1 had 18 patients and a mean +/- SD follow-up of 45.2 +/- 22.2 months. Group 2 had 22 patients and a mean +/- SD follow-up of 42.4 +/- 30.2 months. Six patients (33%) in group 1 and 4 patients (18%) in group 2 had recurrence in period 1 (P =.3). In period 2, 14 patients (78%) in group 1 and 8 patients (36%) in group 2 had recurrence (P =.01). Mean +/- SD recurrence-free survival in period 2 was 15.3 +/- 5.5 months in group 1 and 37.3 +/- 6.3 months in group 2 (P =.001).
CONCLUSIONS:
Long-term oral acyclovir use seems to remain effective in decreasing the number of ocular herpes simplex virus recurrences beyond 12 months.
AuthorsUchoandro B C Uchoa, Renata A Rezende, Maria A Carrasco, Christopher J Rapuano, Peter R Laibson, Elisabeth J Cohen
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 121 Issue 12 Pg. 1702-4 (Dec 2003) ISSN: 0003-9950 [Print] United States
PMID14662588 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Administration, Oral
  • Adult
  • Antiviral Agents (therapeutic use)
  • Blepharitis (prevention & control, virology)
  • Conjunctivitis, Viral (prevention & control, virology)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Herpes Simplex (prevention & control)
  • Humans
  • Iritis (prevention & control, virology)
  • Keratitis, Herpetic (prevention & control)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Secondary Prevention

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: